中华实用儿科临床杂志
中華實用兒科臨床雜誌
중화실용인과림상잡지
Journal of Applied Clinical Pediatrics
2014年
19期
1510-1513
,共4页
鲁阳春%宋洪涛%邹忠东%张敏新%张再重%林晨%王烈
魯暘春%宋洪濤%鄒忠東%張敏新%張再重%林晨%王烈
로양춘%송홍도%추충동%장민신%장재중%림신%왕렬
婴幼儿血管瘤%普萘洛尔%凝胶
嬰幼兒血管瘤%普萘洛爾%凝膠
영유인혈관류%보내락이%응효
Infantile hemangiomas%Propranolol%Gel
目的 评价不同浓度普萘洛尔凝胶外涂治疗婴幼儿体表血管瘤的临床疗效及安全性.方法 将2011年3月至2012年9月南京军区福州总医院普通外科收治的63例婴幼儿体表血管瘤患儿随机数字表法分成A、B、C3组,每组21例,分别采用药物浓度为1%(20 g∶200 mg,A组)、2%(20 g∶400 mg,B组)和3%(20 g∶600 mg,C组)的普萘洛尔凝胶外涂治疗,以均匀涂抹瘤体表面为准,3次/d,随访治疗6个月.详细记录患儿性别、年龄、肿物部位、并发症以及血管瘤大小、质地、颜色、用药后不良反应以及停药后复发情况.涂药后每月返院复查并对疗效进行评价.结果 经过6个月的治疗,A、B、C3组患儿有效率分别为52.38%(11/21例)、57.14%(12/21例)、90.48%(19/21例);彩超检查示3组患儿用药后血管瘤体厚度均明显变薄(P<0.05),3组患儿用药后除少数出现局部皮肤轻微病变外均无全身不良反应,且C组患儿明显优于其他2组(P<0.05).结论 普萘洛尔凝胶治疗婴幼儿血管瘤安全有效,3%浓度的普萘洛尔凝胶疗效要优于其他浓度组药物的疗效.
目的 評價不同濃度普萘洛爾凝膠外塗治療嬰幼兒體錶血管瘤的臨床療效及安全性.方法 將2011年3月至2012年9月南京軍區福州總醫院普通外科收治的63例嬰幼兒體錶血管瘤患兒隨機數字錶法分成A、B、C3組,每組21例,分彆採用藥物濃度為1%(20 g∶200 mg,A組)、2%(20 g∶400 mg,B組)和3%(20 g∶600 mg,C組)的普萘洛爾凝膠外塗治療,以均勻塗抹瘤體錶麵為準,3次/d,隨訪治療6箇月.詳細記錄患兒性彆、年齡、腫物部位、併髮癥以及血管瘤大小、質地、顏色、用藥後不良反應以及停藥後複髮情況.塗藥後每月返院複查併對療效進行評價.結果 經過6箇月的治療,A、B、C3組患兒有效率分彆為52.38%(11/21例)、57.14%(12/21例)、90.48%(19/21例);綵超檢查示3組患兒用藥後血管瘤體厚度均明顯變薄(P<0.05),3組患兒用藥後除少數齣現跼部皮膚輕微病變外均無全身不良反應,且C組患兒明顯優于其他2組(P<0.05).結論 普萘洛爾凝膠治療嬰幼兒血管瘤安全有效,3%濃度的普萘洛爾凝膠療效要優于其他濃度組藥物的療效.
목적 평개불동농도보내락이응효외도치료영유인체표혈관류적림상료효급안전성.방법 장2011년3월지2012년9월남경군구복주총의원보통외과수치적63례영유인체표혈관류환인수궤수자표법분성A、B、C3조,매조21례,분별채용약물농도위1%(20 g∶200 mg,A조)、2%(20 g∶400 mg,B조)화3%(20 g∶600 mg,C조)적보내락이응효외도치료,이균균도말류체표면위준,3차/d,수방치료6개월.상세기록환인성별、년령、종물부위、병발증이급혈관류대소、질지、안색、용약후불량반응이급정약후복발정황.도약후매월반원복사병대료효진행평개.결과 경과6개월적치료,A、B、C3조환인유효솔분별위52.38%(11/21례)、57.14%(12/21례)、90.48%(19/21례);채초검사시3조환인용약후혈관류체후도균명현변박(P<0.05),3조환인용약후제소수출현국부피부경미병변외균무전신불량반응,차C조환인명현우우기타2조(P<0.05).결론 보내락이응효치료영유인혈관류안전유효,3%농도적보내락이응효료효요우우기타농도조약물적료효.
Objective To evaluate the efficacy and safety of different concentrations of propranolol gel in treatment of infantile hemangiomas(IH).Methods Sixty-three consecutive infants with hemangiomas from Mar.2011to Sep.2012 in Department of General Surgery,Fuzhou General Hospital of Nanjing Military Command,were divided randomly into A,B,C groups and respectively treated with propranolol hydrochloride 1% (20 g ∶ 200 mg,A group),2% (20 g:400 mg,B group),3% (20 g:600 mg,C group),evenly applied to the surface of the hemangiomas,3 times a day.Follow-up treatment was performed for 6 months.Details of adverse reactions,gender,age,tumor location,complications,and hemangioma size,texture,color and recurrence after stopping were recorded,and hospital review and efficacy evaluation were performed every month.Results After 6 months of treatment,A group had effective treatment in 11 patients(52.38%),ineffective treatment in 10 patients (47.62%),B group had effective treatment in 12 patients (57.14%),ineffective treatment in 9 patients (42.86%),and C group had effective treatment in 19 patients (90.48%),ineffective treatment in 2 patients(9.52%).After taking color Doppler ultrasound examination revealed IH thickness revealed significantly thinner.Conclusions External use of propranolol hydrochloride gel is an effective option for superficial hemangiomas,And 3% concentration of propranolol gel is superior to the efficacy of the other 2 drugs.